Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks. (2025). Canadian Oncology Today, 2(3), 22–28. https://doi.org/10.58931/cot.2025.2342